Randomized controlled trialHumanClinical Trial, Phase II
Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
The Lancet. Oncology, 2013 Apr. Dobs AS, Boccia RV, Croot CC and 5 others.
Study type
Randomized controlled trial · Clinical Trial, Phase II
Subjects
Human participants (PubMed MeSH: Humans)
Journal
The Lancet. Oncology
Published
2013 Apr
PubMed
Indexed under
MeSH terms assigned by the National Library of Medicine.
AmidesAnilidesArgentinaBody Mass IndexCachexiaDouble-Blind MethodFemaleHumansMaleMusclesNeoplasmsUnited States
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page